Provided by Tiger Fintech (Singapore) Pte. Ltd.

Artelo Biosciences, Inc.

8.35
-0.6800-7.53%
Post-market: 8.350.00000.00%19:00 EDT
Volume:16.53K
Turnover:145.37K
Market Cap:5.88M
PE:-0.46
High:9.17
Open:9.17
Low:8.20
Close:9.03
52wk High:28.60
52wk Low:4.92
Shares:704.43K
Float Shares:700.00K
Volume Ratio:0.05
T/O Rate:2.36%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-17.9685
EPS(LYR):-18.2923
ROE:-190.70%
ROA:-89.21%
PB:9.02
PE(LYR):-0.46

Loading ...

Artelo Biosciences Secures $1.425 Million Through At-the-Market Private Placement Financing

Reuters
·
Jun 26

BRIEF-Artelo Biosciences Inc - Regains Nasdaq Minimum Bid Price Compliance

Reuters
·
Jun 14

Artelo Biosciences Announces 6-for-1 Reverse Stock Split Effective June 13, 2025

Reuters
·
Jun 14

Artelo Biosciences Inc trading halted, news pending

TIPRANKS
·
Jun 13

Artelo Biosciences Cut to Hold From Buy by D. Boral Capital

Dow Jones
·
Jun 11

Artelo Biosciences to Implement 6-for-1 Reverse Stock Split; Shares Down

MT Newswires Live
·
Jun 11

Artelo Biosciences downgraded to Hold from Buy at D. Boral Capital

TIPRANKS
·
Jun 11

Artelo Biosciences Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Jun 06

Artelo Biosciences Reports Q1 2025 Financial Results

TIPRANKS
·
May 28

Artelo Biosciences Faces Nasdaq Compliance Challenge

TIPRANKS
·
May 24

Artelo Biosciences Inc. Faces Nasdaq Compliance Challenge Over Stockholders' Equity Requirement

Reuters
·
May 24

Artelo Biosciences Q1 EPS $(0.72) Misses $(0.13) Estimate

Benzinga
·
May 13

Press Release: Artelo Biosciences Provides Business Update and Reports First Quarter 2025 Financial Results

Dow Jones
·
May 13

Artelo Biosciences Inc expected to post a loss of 13 cents a share - Earnings Preview

Reuters
·
May 10

Artelo Biosciences Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Apr 28

Artelo Biosciences Announces Publication of New Peer-Reviewed Research Demonstrating ART26.12’s Effectiveness in Treating Psoriasis

GlobeNewswire
·
Apr 28

Artelo Biosciences Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Apr 02

New Strong Sell Stocks for March 6th

Zacks
·
Mar 06

Artelo Biosciences Reports 2024 Financial Results and Clinical Progress

TIPRANKS
·
Mar 06

Artelo Biosciences Price Target Maintained With a $5.00/Share by HC Wainwright & Co.

Dow Jones
·
Mar 04